Dr. Raje on the Efficacy of Belantamab Mafodotin in Multiple Myeloma

Dr. Raje on the Efficacy of Belantamab Mafodotin in Multiple Myeloma

Impact of prior therapies on efficacy of belantamab mafodotin in R/R myelomaПодробнее

Impact of prior therapies on efficacy of belantamab mafodotin in R/R myeloma

Dr. Raje on the Potential Utility of Belantamab Mafodotin in Multiple MyelomaПодробнее

Dr. Raje on the Potential Utility of Belantamab Mafodotin in Multiple Myeloma

MagnetisMM-1: investigating the efficacy of elranatamab in patients with R/R multiple myelomaПодробнее

MagnetisMM-1: investigating the efficacy of elranatamab in patients with R/R multiple myeloma

Dr. Raje Discusses the Tolerability of bb2121 in MyelomaПодробнее

Dr. Raje Discusses the Tolerability of bb2121 in Myeloma

Cost Effectiveness Comparison of Belantamab Mafodotin and Selinexor in RRMMПодробнее

Cost Effectiveness Comparison of Belantamab Mafodotin and Selinexor in RRMM

Dr. Raje on Efficacy With Melflufen in Triple-Refractory MyelomaПодробнее

Dr. Raje on Efficacy With Melflufen in Triple-Refractory Myeloma

Real-world safety and efficacy of belantamab mafodotin in R/R multiple myelomaПодробнее

Real-world safety and efficacy of belantamab mafodotin in R/R multiple myeloma

A real-world analysis of belantamab mafodotin in patients with R/R multiple myelomaПодробнее

A real-world analysis of belantamab mafodotin in patients with R/R multiple myeloma

Dr. Lonial on Data With Belantamab Mafodotin in Multiple MyelomaПодробнее

Dr. Lonial on Data With Belantamab Mafodotin in Multiple Myeloma

Dr. Raje on Remaining Questions in Multiple MyelomaПодробнее

Dr. Raje on Remaining Questions in Multiple Myeloma

BCMA-Targeted Therapy in RRMM: Results From the DREAMM-1 TrialПодробнее

BCMA-Targeted Therapy in RRMM: Results From the DREAMM-1 Trial

Dr. Raje on Future Research With BiTEs in Multiple MyelomaПодробнее

Dr. Raje on Future Research With BiTEs in Multiple Myeloma

DREAMM-2: Belantamab mafodotin for R/R myelomaПодробнее

DREAMM-2: Belantamab mafodotin for R/R myeloma

Immunotherapy for treating multiple myelomaПодробнее

Immunotherapy for treating multiple myeloma

Blenrep (belantamab mafadotin) for multiple myeloma — Dr. Jesus Berdeja | MCRT Webcast August 22Подробнее

Blenrep (belantamab mafadotin) for multiple myeloma — Dr. Jesus Berdeja | MCRT Webcast August 22

DREAMM-9: belantamab mafodotin plus VRd vs VRd in TI NDMMПодробнее

DREAMM-9: belantamab mafodotin plus VRd vs VRd in TI NDMM

Dr. Raje Discusses the Impact of bb2121in MyelomaПодробнее

Dr. Raje Discusses the Impact of bb2121in Myeloma

Evolution of the multiple myeloma therapeutic landscapeПодробнее

Evolution of the multiple myeloma therapeutic landscape

The potential role of belantamab mafodotin in multiple myelomaПодробнее

The potential role of belantamab mafodotin in multiple myeloma